Literature DB >> 10718679

Diagnosis and treatment of sleep disorders caused by co-morbid disease.

S Chokroverty1.   

Abstract

Sleep disorders, both insomnia and hypersomnia, are commonly associated with various co-morbid conditions, including general medical and neurologic disorders, psychiatric illnesses, and secondary or symptomatic restless legs syndrome/periodic limb movements in sleep. Diagnosis of the co-morbidity is the first step in treatment, followed by an assessment of the sleep disturbance. This begins with a complete history and physical examination, followed by laboratory testing such as polysomnography, multiple sleep latency testing, and actigraphy. The treatment of sleep disorders caused by co-morbid conditions is discussed under seven categories, including the use of general measures (e.g., sleep hygiene, encouraging patients to develop good sleep habits, medication), treatment of the co-morbid condition, treatment of insomnia, treatment of excessive daytime somnolence, treatment of parasomnias, treatment of sleep-wake schedule disorders, and treatment of secondary or symptomatic restless legs syndrome.

Entities:  

Mesh:

Year:  2000        PMID: 10718679

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Paeoniflorin exerts analgesic and hypnotic effects via adenosine A1 receptors in a mouse neuropathic pain model.

Authors:  Dou Yin; Yuan-Yuan Liu; Tian-Xiao Wang; Zhen-Zhen Hu; Wei-Min Qu; Jiang-Fan Chen; Neng-Neng Cheng; Zhi-Li Huang
Journal:  Psychopharmacology (Berl)       Date:  2015-10-29       Impact factor: 4.530

2.  Sleep Disturbances Following Traumatic Brain Injury.

Authors:  Vani Rao; Pamela Rollings
Journal:  Curr Treat Options Neurol       Date:  2002-01       Impact factor: 3.598

3.  Dopamine D1 and D2 receptors mediate analgesic and hypnotic effects of l-tetrahydropalmatine in a mouse neuropathic pain model.

Authors:  Yuan-Yuan Liu; Tian-Xiao Wang; Ji-Chuan Zhou; Wei-Min Qu; Zhi-Li Huang
Journal:  Psychopharmacology (Berl)       Date:  2019-06-06       Impact factor: 4.530

4.  Sleep disturbance as a predictor of time to drug and alcohol use treatment in primary care.

Authors:  Lisa R Fortuna; Benjamin Cook; Michelle V Porche; Ye Wang; Ana Maria Amaris; Margarita Alegria
Journal:  Sleep Med       Date:  2018-01-09       Impact factor: 3.492

5.  Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm.

Authors:  Jiajun Shi; Jacqueline K Wittke-Thompson; Judith A Badner; Eiji Hattori; James B Potash; Virginia L Willour; Francis J McMahon; Elliot S Gershon; Chunyu Liu
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-10-05       Impact factor: 3.568

6.  Diagnosis and treatment of sleep disorders: a brief review for clinicians.

Authors:  Vivien C Abad; Christian Guilleminault
Journal:  Dialogues Clin Neurosci       Date:  2003-12       Impact factor: 5.986

7.  Analysis of Antidepressant, Benzodiazepine Anxiolytic, and Hypnotic Use When Treating Depression, Anxiety, and Aggression in Pain Clinic Patients Treated for Neuropathic Pain.

Authors:  Marcin Kolacz; Dariusz Kosson; Ewa Puchalska-Kowalczyk; Malgorzata Mikaszewska-Sokolewicz; Barbara Lisowska; Malgorzata Malec-Milewska
Journal:  Life (Basel)       Date:  2022-03-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.